Seeing Is Believing

Currently out of the existing stock ratings of Matt Bottomley, 20 are a HOLD (41.67%), 17 are a BUY (35.42%), 11 are a SELL (22.92%).
Analyst Matt Bottomley, carries an average stock price target met ratio of 52.08% that have a potential upside of 42.44% achieved within 311 days. Previously, Matt Bottomley worked at MIZUHO.
Matt Bottomley’s has documented 72 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACB, Aurora Cannabis at 08-Aug-2024.
Analyst best performing recommendations are on APHA (APHRIA).
The best stock recommendation documented was for APHA (APHRIA) at 4/13/2021. The price target of $18 was fulfilled within 17 days with a profit of $3.15 (21.21%) receiving and performance score of 12.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Dec-2024
$9
$5.74 (176.07%)
1 years 3 months 24 days ago
(11-Dec-2024)
0/1 (0%)
$4.66 (107.37%)
Buy Since 08-Aug-2024
1 years 7 months 27 days ago
(08-Aug-2024)
1/2 (50%)
$-4.52 (-84.96%)
487
Hold Since 27-Jun-2024
$3
1 years 9 months 8 days ago
(27-Jun-2024)
4/4 (100%)
$-10 (-76.92%)
544
Hold Since 23-Sep-2020
$2
$-1.44 (-41.86%)
3 years 3 months 7 days ago
(28-Dec-2022)
2/3 (66.67%)
$-6.47 (-76.39%)
718
Hold
3 years 10 months 19 days ago
(16-May-2022)
4/7 (57.14%)
$6.37 (31.42%)
9
What Year was the first public recommendation made by Matt Bottomley?